Privia Health Group, Inc. — Form 8-K Summary
Report date: June 7, 2022. The filing reports a Regulation FD disclosure under Item 7.01 and furnishes investor presentation materials for meetings with institutional investors and analysts. Exhibit 99.1 is identified as the company’s “Investor Presentation Slides — June 2022,” but the presentation content is not included in the provided filing text.
Business Context and Reporting Period
Privia Health Group, Inc. is a Delaware corporation headquartered in Arlington, Virginia. Its common stock trades on The Nasdaq Global Select Market under the symbol PRVA. This filing does not report results for a specific fiscal quarter or year and does not include financial statements.
Financial Metrics and Liquidity
The provided filing text does not provide clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, operating metrics, or other financial results.
Material Changes Versus Prior Period
No period-over-period financial or operating changes are disclosed in the provided filing text. Any information that may have been included in the attached investor presentation is not available here.
Guidance, Outlook, Risks, and Unusual Items
- The company states that the furnished information may be amended or updated through a subsequent Form 8-K, later filing, or other means.
- The filing disclaims any obligation to publicly update forward-looking statements or the circumstances underlying them.
- The disclosure is furnished under Regulation FD and is not deemed filed for purposes of Section 18 of the Exchange Act or otherwise subject to that section’s liabilities.
- No specific guidance, outlook, risk factor, contingency, transaction, or unusual item is described in the provided text.
Key Facts for Investors to Verify
- Review Exhibit 99.1 and the company’s investor relations website for the June 2022 presentation and any financial or operating metrics.
- Verify whether the presentation contains forward-looking guidance, definitions of non-GAAP measures, or revised expectations.
- Confirm any subsequent Form 8-K or other filing that amends or updates the furnished information.
- Note that the company identified itself as an emerging growth company and elected to use the extended transition period for new or revised accounting standards.